106 related articles for article (PubMed ID: 16389875)
1. [Phytopharmacology. New relaxed regulation in Europe].
Ecker-Schlipf B
Med Monatsschr Pharm; 2005 Dec; 28(12):448-9. PubMed ID: 16389875
[No Abstract] [Full Text] [Related]
2. 'Soft medicine' is not always soft: the original sin of German drug legislation.
Happle R
Dermatology; 2007; 214(2):105-7. PubMed ID: 17341856
[No Abstract] [Full Text] [Related]
3. Does marijuana have a future in pharmacopoeia?
Frazzetto G
EMBO Rep; 2003 Jul; 4(7):651-3. PubMed ID: 12835749
[TBL] [Abstract][Full Text] [Related]
4. Innovation in Phytotherapy: Is a New Regulation the Feasible Perspective in Europe?
Minghetti P; Franzè S; Zaccara V; Raso F; Morazzoni P
Planta Med; 2016 May; 82(7):591-5. PubMed ID: 27135627
[TBL] [Abstract][Full Text] [Related]
5. The end of the beginning?
Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
[No Abstract] [Full Text] [Related]
6. [Regulatory aspects of the drug authorization for children. USA, Europe and Germany].
Franken A
Pharm Unserer Zeit; 2009; 38(1):44-9. PubMed ID: 19132678
[No Abstract] [Full Text] [Related]
7. Regulation of the production and use of radiopharmaceuticals in Germany and Europe.
Kuwert T
J Clin Pharmacol; 2001 Jul; 41(S7):121S-122S. PubMed ID: 11452722
[No Abstract] [Full Text] [Related]
8. Policies on drugs in the new Europe.
Smith T
BMJ; 1990 Jun; 300(6738):1476-7. PubMed ID: 2372598
[No Abstract] [Full Text] [Related]
9. Informed consent--a new approach to drug regulation?
Nutt DJ
J Psychopharmacol; 2006 Jan; 20(1):3-4. PubMed ID: 16354734
[No Abstract] [Full Text] [Related]
10. Herbal research: the good, the bad and the worrying.
Mills SY
Complement Ther Med; 2007 Mar; 15(1):1-2. PubMed ID: 17352965
[No Abstract] [Full Text] [Related]
11. Orphan drug development across Europe: bottlenecks and opportunities.
Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG
Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178
[TBL] [Abstract][Full Text] [Related]
12. The clinical pharmacologist in drug regulation: a European perspective.
Rawlins MD
Br J Clin Pharmacol; 1996 Jul; 42(1):59-61. PubMed ID: 8807145
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation in drug response: implications for the development and regulation of drugs.
Johnson DE; Park BK; Smith DA
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):29-31. PubMed ID: 18175264
[No Abstract] [Full Text] [Related]
14. Canada lags in acceptance, regulation of herbal remedies.
Michaels E
CMAJ; 1986 Sep; 135(5):547-8. PubMed ID: 3742398
[No Abstract] [Full Text] [Related]
15. [Welcome to phytotherapy].
Meier B
Forsch Komplementmed; 2014; 21 Suppl 1():1. PubMed ID: 25012281
[No Abstract] [Full Text] [Related]
16. Old laws stop drugs being used in valuable new ways.
Berger SP
Nature; 2007 Oct; 449(7165):972. PubMed ID: 17960214
[No Abstract] [Full Text] [Related]
17. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
Ludwig WD
Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
[No Abstract] [Full Text] [Related]
18. Pain treatment, drug diversion, and the casualties of war.
Burgess F
Pain Med; 2006; 7(6):474-5. PubMed ID: 17112360
[No Abstract] [Full Text] [Related]
19. Biosimilars legislation awakens data exclusivity debate.
Hutson S
Nat Med; 2009 Nov; 15(11):1242. PubMed ID: 19893548
[No Abstract] [Full Text] [Related]
20. Bad execution.
Nature; 2007 Jun; 447(7145):613-4. PubMed ID: 17554265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
